Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer
Camilla Zimmermann(University Health Network), Lisa W. Le(University Health Network), Neesha C. Dhani(Princess Margaret Cancer Centre), Jean Mathews(University Health Network), Aaron R. Hansen(Princess Margaret Cancer Centre), Stéphanie Lheureux(Princess Margaret Cancer Centre), Leonie Herx(Queen's University), Philippe L. Bédard(Princess Margaret Cancer Centre), Breffni Hannon(University of Toronto), Srikala S. Sridhar(Princess Margaret Cancer Centre), Doris Howell(Princess Margaret Cancer Centre), Gary Rodin(Princess Margaret Cancer Centre), Deborah Dudgeon(Cancer Care Ontario), Rebecca M. Prince(University Health Network), Madeline Li(University Health Network), Jennifer J. Knox(National Cancer Center), Amit M. Oza(Ontario Institute for Cancer Research), Christopher M. Booth(Queen's University), Brittany Chow, Geoffrey Liu(Princess Margaret Cancer Centre), Monika K. Krzyzanowska(Sunnybrook Health Science Centre), Nadia Swami(University Health Network), Natasha B. Leighl(Princess Margaret Cancer Centre), Ashley Pope(University Health Network), Anne Rydall(University Health Network)
Cited by 71
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k